U.S. markets closed

Awakn Life Sciences Corp. (AWKNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.7084-0.1027 (-5.67%)
At close: 3:14PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.8111
Open1.7445
BidN/A x N/A
AskN/A x N/A
Day's Range1.6977 - 1.7445
52 Week Range1.3947 - 1.9100
Volume2,450
Avg. Volume1,738
Market Cap41.831M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0910
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Newsfile

      Awakn Life Sciences Acquires Exclusive Rights to MDMA Research from Imperial College London

      This Was the World's First Published Study Assessing MDMA-Assisted Psychotherapy as a Treatment for Addiction Toronto, Ontario--(Newsfile Corp. - September 23, 2021) - Awakn Life Sciences Corp., (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (Awakn) a biotechnology company developing and delivering psychedelic therapeutics to treat addiction, announced today that it has acquired the exclusive rights to the data from the phase IIa Bristol Imperial MDMA in Alcoholism Study (BIMA) from Imperial College Lond

    • Market Exclusive

      Weekly Roundup on the Cannabis Sector

      Key Takeaways: Akerna Corp. Acquires 365 Cannabis For $17M, Seeks To Create Most Comprehensive ERP System In Cannabis Industry. HEXO Corp. Achieves Carbon Neutrality. Fire & Flower Holdings Corp. Announces its Financial and Operational Results for the Fiscal Second Quarter Ended July 31, 2021. This was followed by Reports of Completed Acquisitions of PotGuide and […] The post Weekly Roundup on the Cannabis Sector appeared first on Market Exclusive.

    • Newsfile

      Awakn Life Sciences to Present at the Oppenheimer and Maxim Group September Investor Conferences

      Toronto, Ontario--(Newsfile Corp. - September 20, 2021) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) ('Awakn'), a biotechnology company with clinical operations developing and delivering psychedelic medicines to better treat Addiction, announced today that Anthony Tennyson, Chief Executive Officer, will present in the following upcoming September investor conferences. Oppenheimer Fall Healthcare Life Sciences & MedTech SummitDate: Monday, September 20th - Thursday, September 23rdPresen